Document is current
Any future updates will be listed below
-
Authors
Udomruk, Sasimol
Sutthitthasakul, Songphon
Bunsermvicha, Nuttida
Pinyopornpanish, Kanokwan
Pruksakorn, Dumnoensun
Charoenkwan, Phasit
Yongpitakwattana, Petlada
Khounkaew, Kanlaya
Jaimalai, Thanapak https://orcid.org/0009-0004-3342-5213
Duangsan, Treephum
Orrapin, Santhasiri
Moonmuang, Sutpirat
Noisagul, Pitiporn https://orcid.org/0000-0001-5351-9998
Pasena, Arnat
Suksakit, Pathacha
Gamngoen, Ratikorn
Teeyakasem, Pimpisa
Charoentum, Chaiyut
Kongkarnka, Sarawut
Lapisatepun, Worakitti
Chaiyawat, Parunya
-
Funding
Funding for this research was provided by:
CMU | Faculty of Medicine, Chiang Mai University
- License Information
-
More Information
Article History
Received: 5 June 2025
Accepted: 4 February 2026
First Online: 17 February 2026
Competing interests
: Sasimol Udomruk, Songphon Sutthitthasakul, Worakitti Lapisatepun, and Parunya Chaiyawat report a petty patent application (Thai-2403001380) currently under review, licensed to CELiver, for the cfDNA-based automated capillary electrophoresis method for liver cancer screening. All other authors declare no competing interests.
